NCT01602432 2023-02-27
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute
Withdrawn
Ottawa Hospital Research Institute
Xperiome
X4 Pharmaceuticals
Memorial Sloan Kettering Cancer Center